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The objective of this study was to investigate the formation and forming mechanism of the related 
substance E in potassium clavulanate production. The impurity with retention time of 11.1 min in 
potassium clavulanate final product was confirmed as the related substance E by high performance liquid 
chromatography with tandem mass spectrometric detection (HPLC-MS/MS).The related substance E 
analysis during the production of clavulanic acid showed that this impurity could be formed during 
both the fermentation and purification processes, especially in the later fermentation stage, filtration 
concentration and back-extraction procedure. Clavulanic acid was the precursor of the related substance 
E. Studies on its forming mechanism showed that the related substance E was formed by the combination 
of the imino group of one molecule of clavulanic acid with the carboxyl group of another molecule of 
clavulanic acid with the opening of β-lactam ring. Results of a multi-factor orthogonal test confirmed 
that the concentration of clavulanic acid was the dominant factor to accelerate the reaction, while the 
temperature was another contributing factor. The pH 5.0-6.5 had little impact on the generation of the 
related substance E.
Uniterms: Potassium clavulanate/production. Clavulanic acid/formation of the Related substance E. 
Related substance E/formation. Related substance E/forming mechanism High performance liquid 
chromatography/biotechnological process.
O objetivo deste estudo foi investigar a formação da substância E e o respectivo mecanismo na produção 
de clavulanato de potássio. Confirmou-se a impureza com tempo de retenção de 11,1 min no produto 
final, clavulanato de potássio, como substância E, por meio de cromatografia líquida de alta eficiência, 
em conjunto com detecção por espectrometria de massas (CLAE-MS-MS). A análise da substância 
relacionada E durante a produção do ácido clavulânico mostrou que essa impureza pode ser formada 
tanto durante a fermentação quanto durante os processos de purificação, especialmente no estágio final 
de fermentação, filtração, concentração e procedimento de extração. O ácido clavulãnico foi o precursor 
da substância E. Estudos no mecanismo de sua formação mostraram que a substância E formou-se 
pela combinação do grupo imina da molécula do ácido clavulânico com o grupo carboxílico de outra 
molécula de ácido clavulânico, com a abertura do anel β-lactâmico. Resultados do teste ortogonal 
multifatorial confirmaram que a concentração do ácido clavulânico foi o fator dominante para acelerar 
a reação, enquanto a temperatura foi outro fator que contribuiu. O pH de 5,0 a 6,5 teve pouco impacto 
na geração da substância E.
Unitermos: Clavulanato de potássio/produção. Ácido clavulânico/formação da substância E relacionada. 
Substância E relacionada/mecanismo de formação Cromatografia líquida de alta eficiência/processo 
biotecnológico.
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INTRODUCTION
Clavulanic acid, one of the lactamase inhibitors, 
is a secondary metabolite produced by Streptomyces 
clavuligerus (Shetty et al., 2010; Saudagar, Singhal, 
2007).It has been shown that clavulanic acid has 
antibacterial activity against a wide variety of aerobic and 
anaerobic bacteria (Silva et al., 2009; Dinceret al., 2004). 
Several methods such as micellelectrokinetic capillary 
chromatography (MEKC), high performance liquid 
chromatography (HPLC), and potentiometric methods 
are used to determine the concentration of clavulanic 
acid. Studies showed that clavulanic acid has chemical 
instability and is degraded rapidly into complexes 
including multiple components (Parag, 2008; Sunderland, 
Vahdat, 2009). Seven related substances (assigned as 
A–G, respectively) have been found existing in potassium 
clavulanate as noted in European Pharmacopoeia, among 
which the related substance A, B, C, D, and F were 
formed by the catabolites of clavulanic acid under acid 
or alkali conditions (Malcolm, 1984; Haginaka, 1985). 
The related substance G was produced by L-tyrosine 
and succinate, the precursors, catalyzed by a series of 
extracellular enzymes. The related substance E was one 
of the main impurities in the commercially available 
potassium clavulanate (Zhong et al., 2008).So far there 
has been little relevant research on the related substance 
E and its forming mechanism. In this study, the impurity 
with retention time of 11.1 min in potassium clavulanate 
was confirmed as the related substance E by HPLC-MS/
MS and the forming mechanism of the related substance E 
was investigated according to its chemical structure. The 
effect of varied reaction parameters on the formation of 
the related substance E was studied, which would be useful 
to reduce the concentration of the related substance E and 
improve the quality of potassium clavulanate.
MATERIAL AND METHODS
Microbiol strains
The industrial production strain was Streptomyces 
clavuligeru F613-1.
Reagents
Ammonium formate, formic acid and methanol 
were products of Tedia, United States of America with 
LC grade. Ultra-pure water used for the preparation of 
running buffers and standard solutions were obtained 
by a Milli-Q system. All other reagents such as acetone, 
isopropyl alcohol, ethanol, acetic acid, sodium hydroxide 
were of analytical reagent grade, which were produced by 
Sinopharm Chemical Reagent Co. Ltd.
Standard and preparations
Clavulanate lithium standard, crude product and 
high purity of clavulanate tert-butylamine, potassium 
clavulanate and industrial fermentation medium were 
provided by Lunan Pharmaceutical Co. (Shandong, 
China).
Instrumental parameters
Agilent 1100 HPLC and Agilent 1200-6410 LC-MS/
MS systems were used to determine the concentration 
and structure of the related substance E. A Mettler 
AL104 electronic analytical balance was used to weigh 
the sample. A Thermostat water bath and DLSB low 
temperature bath was used to control the temperature in 
the orthogonal experiment.
HPLC analysis conditions
Mobile phase A was 0.03 mol/L ammonium formate 
solution (pH 4), and mobile phase B was an equivalent 
mixture of methanol and mobile phase A. The elution 
gradient was 0–4 min mobile phase A 100%, 4-15 min 
mobile phase B 0-50%, 15-18 min mobile phase B 50-0%, 
18-30 min mobile phase A 100% and the flow rate was 
1 mL/min. The column temperature inside the column was 
maintained at 40 °C. Detection was carried out at 230 nm. 
The injection volume was 20 µL. Samples were well 
separated on an inertsil ODS-3 chromatographic column 
(4.6 mm×150 mm, 5 µm).
HPLC-MS/MS analysis conditions
HPLC analysis conditions were the same as above 
with post-column split, electrospray ionization, negative 
ion, MS2 scan. The collision energy was 5 V.
The related substance E analysis during the 
production of clavulanic acid
The production process of clavulanic acid consisted 
of fermentation, filtration concentration(microfiltration, 
ultra-filtration, reverse osmosis), extraction, back-
extraction, crystallization (crude product) and re-
crystallization (final product). Blank medium (sterilized) 
and the fermentation liquids of different periods (24 h, 
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48 h, 72 h and 96 h, respectively) during the fermentation 
process were sampled, and the filtration concentrate, 
extraction phase, back-extraction concentrate, crude 
product and final product during the purification process 
were also collected. All the samples were treated with 
the following methods according to their characteristics 
and the concentration of clavulanic acid, and the related 
substance E was determined by HPLC, respectively.
Samples were obtained as follows. Precisely 5 g of 
fermentation liquid was weighed and diluted to 25 mL 
with mobile phase A. The aqueous phase was collected 
after centrifugation (at a speed of 8000 rpm for 4 min) 
and filtered (with 0.22 µm membrane). As for the aqueous 
samples, they were diluted to a final concentration of 
1.0 mg/mL clavulanic acid. As for the samples in organic 
phase, they were blown dry with nitrogen, then dissolved 
and diluted with mobile phase A. As for the solid samples, 
precisely 0.25 g was weighed and then diluted into 25 mL 
with mobile phase A.
Studies on the factors affecting the formation of 
the related substance E
Clavulanate tert-butylamine of 99.5% purity was 
prepared with the following procedure: the crude product 
was weighed and solubilized in 4 °C with ultra-pure water, 
then adjusted to pH 6.2 with acetic acid. The solution was 
filtered with a 0.22 μm membrane and then the sample 
was crystallized in acetone. The crystal was re-dissolved 
in ultra-pure water, re-crystallized with ethanol and then 
the crystal was washed with isopropanol and acetone 
successively. The purity of the crystal was 99.5% or above 
when determined by HPLC, while the related substance 
E was not detected.
A three-factor and four-level orthogonal experiment 
was designed with such three factors as concentration 
of clavulanic acid, temperature, and pH. Four levels for 
each factor were set: 50, 100, 150, and 200 g/L for the 
concentration of clavulanic acid; 5, 10, 15, and 20 °C for 
temperature, 5.0, 5.5, 6.0 and 6.5 for pH. Appropriate 
amounts of clavulanate tert-butylamine with 99.5% 
purity were weighed and dissolved in ultra-pure water. 
The orthogonal experiment was performed according 
to the above design, and the changes in concentration of 
clavulanic acid and the related substance E in 120 min 
were determined. The effect of the oxygen on the forming 
velocity of the related substance E under the conditions 
of air or nitrogen protection at the level of 100 g/L 
concentration, 15 °C and pH 6.0, was also investigated.
RESULTS AND DISCUSSION
The structure identification of the impurity at 
11.1 min
An impurity appeared at the retention time of 11.1 
min in some final products of potassium clavulanate. The 
maximum concentration of the impurity may reach 0.5% 
(Figure 1). HPLC analysis showed that the impurity is a 
single substance and the retention time was similar to that 
of the related substance E as noted in the part of potassium 
clavulanate in European Pharmacopoeia (2005). So we 
speculated that the impurity was the related substance E 
(Figure 2).
HPLC is a valid method for the determination of 
free arginine, glutamine,and β-alanine in nutritional 
products and dietary supplements (Jeffrey, Paul, 2012). 
HPLC-MS/MS is also a method to analyse tebuconazole, 
FIGURE 1- HPLC chromatogram of clavulanic acid and the related substance E. A: clavulanic acid; B: the related substance E.
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tetraconazole enantiomers and plant growth regulators 
(Ma et al., 2013; Zhang et al., 2012). Tandem mass 
spectrometry analysis was executed by HPLC-MS/MS in 
order to define the exact chemical structure of the related 
substance E. First-order and secondary mass spectrogram 
were shown in Figure 3a and Figure 3b, respectively. 
Results of the mass spectrometry showed its molecular ion 
mass-to-charge ratio was m/z 397, the same as that of the 
related substance E in European Pharmacopoeia. All the 
data showed that the impurity was the related substance E.
Tandem mass spectrometry analysis showed that a 
molecular ion with m/z 397 could be dissociated into such 
fragments as m/z 353, m/z 309, m/z 291, m/z 279, m/z 
263, m/z 253, m/z 249, m/z 237, m/z 221, m/z 180, and 
m/z 154. Combining the characteristics of fragment ions, 
relative abundance, the general rule of ion fragmentation 
mechanism, and the chemical structure of the related 
substance E, we speculated the possible fragmentation 
path of molecular ion with m/z 397 (Figure 4).
Analysis of the producing stage of the related 
substance E
The changes in concentration of the related substance 
E during the fermentation and purification process were 
studied in order to analyse the possible synthesis pathway 
of the related substance E. The concentrations of the 
related substance E at the time of 0 h, 24 h, 48 h, 72 h, and 
96 h during fermentation process are shown in Figure 5. 
There was neither the related substance E nor clavulanic 
acid in the sterilized blank medium. Approximately 
0.3 g/L clavulanic acid was detected at the 24 h stage of 
fermentation, while none of the related substance E was 
detected. The concentration of the clavulanic acid reached 
2.07 g/L at the stage of 48 h, when the related substance 
E was 0.0004 g/L. After this time, the concentrations of 
clavulanic acid and the related substance E increased 
synchronously. The concentration of clavulanic acid and 
the related substance E reached 4.87 g/L and 0.044 g/L 
respectively when fermentation terminated, and the 
relative amount of the related substance E to clavulanic 
acid was 0.91%. Results showed that the formation of 
the related substance E was later than the synthesis of 
clavulanic acid, and its concentration increased with the 
FIGURE 2 - Chemical structure of the related substance E.
FIGURE 3 - Mass spectra of the substance with retention time of 11.1 min. a. First-order mass spectrum; b. Secondary mass spectrum.
Studies on the formation and forming mechanism of the related substance E in potassium clavulanate production by HPLC-MS/MS 395
FIGURE 4 - Possible fragmentation path of the related substance E.
increase of clavulanic acid, which was different from the 
phenomenon that the related substance G was formed 
almost synchronously with clavulanic acid during the 
fermentation process.
During the purification process, the relative 
amount of the related substance E was detected at each 
procedure (Figure 6). The relative amount of the related 
substance E was 0.91% at the final fermentation stage, 
and it decreased to 0.63%, 0.34%, 0.16%, respectively 
in extraction phase, crude product, and final product. 
FIGURE 5 - Concentration of the related substance E during 
fermentation process. A:clavulanic acid, B:the related substance 
E; 1:Sterilized blank medium (0h); 2:Early stage of fermentation 
(24h); 3:Medium stage of fermentation (48h); 4:Later stage of 
fermentation (72h); 5:Final stage of fermentation (96h)
All the above three processes could remove most of the 
related substance E, while the relative amount of the 
related substance E increased significantly in filtration 
concentrate and back-extraction concentrate compared 
with the corresponding previous process, fermentation and 
extraction, with a great increase of 21.98% and 36.51%, 
respectively. So the related substance E may be formed 
during the concentration stage, which may be related to 
the increase of clavulanic acid. Considering the formation 
of the related substance E during the fermentation stage, 
we could confirm that the related substance E was formed 
during the fermentation and concentration process, which 
was related to the increase of clavulanic acid. Combined 
with the chemical structure of the related substance E, we 
could deduce that clavulanic acid is the precursor of the 
related substance E.
Inference for the forming mechanism of the 
related substance E
With the analysis of the chemical structure of the 
related substance E (Figure 2), we find that the molecular 
weight of the related substance E was twice that of 
clavulanic acid. We could infer from the formula that the 
related substance E would be formed from one molecule 
of clavulanic acid and one molecule of its β-lactam ring 
opening decomposition product. So the related substance 
E may be synthesized from two molecules of clavulanic 
acid. We prepared a 100 g/L clavulanate tert-butylamine 
solution of 99.5% purity at room temperature in order to 
verify whether enzyme was required for the production of 
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the related substance E. Results showed that the content 
of the related substance E increased with prolonged time 
(Table I). So, the related substance E could be synthesized 
in a chemical process and the related substance E may 
be formed in the same way during the fermentation and 
purification process.
Clavulanic acid had similar chemical properties as 
other β-lactam antibiotics, and the instability of clavulanic 
acid was ten times that of penicillin (McGowan et al., 
1998).When the β-lactam ring of clavulanic acid reacted 
with water or other nucleophilic groups, the hydrolysis of 
the amide bond may lead to the opening of the β-lactam 
ring, resulting in the degradation of clavulanic acid 
(Malcolm, 1984). The forming mechanism of the related 
substance E may be described in Figure 7 as follows: 1) 
in weak acidic conditions, acyl groups in β-lactam ring of 
clavulanic acid molecule (I) may be oxygen protonated, 
with the result that the carbonyl carbon is more susceptible 
to nucleophilic attack; 2) such weak nucleophiles as water 
attack protonated carbonyl carbon to form the intermediate 
product (III); 3) the proton would be transferred to a tertiary 
N, when a lone pair of electrons separated themselves 
from –OH leading to the opening of the β-lactam ring to 
form oxonium salt (V); 4) a proton is separated from the 
oxonium salt in order to form the intermediate product 
(VI); 5) the imino group of the intermediate product (VI) 
is activated when being attacked by water, the protonated 
carboxyl carbon of another molecule of clavulanic acid 
is attacked by the resulting active nitrogen, and oxonium 
salt is formed(VIII); 6) the proton is separated from the 
oxonium salt and the amide bond formed, leading that 
the related substance E (IX) formed. The above specific 
reaction route is shown in Figure 7.
FIGURE 6 - The relative percentage amount of the related 
substance E during the purification process. A: Fermentation 
broth; B: Filtration concentrate; C: Extraction phase; D: 
Reversed concentrate; E: Crude salt; F: Final product.
FIGURE 7 - Hypothesis on forming mechanism of the related substance E.
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TABLE I - Levels of the orthogonal design on the factors affecting 
the synthesis of the related substance E
Levels
Factors
A. Concentration
(g/L)
B. Temperature
(°C)
C.  
pH 
1 50 5 5.0
2 100 10 5.5
3 150 15 6.0
4 200 20 6.5
TABLE II - Results of the orthogonal design on the factors 
affecting synthesis of the related substance E
No. A B C
Relative 
Concentration 
(×10-2/%)
1 1 1 1 1.2
2 1 2 2 3.2
3 1 3 3 4.4
4 1 4 4 11.6
5 2 1 2 9.1
6 2 2 1 11.0
7 2 3 4 12.2
8 2 4 3 15.6
9 3 1 3 12.5
10 3 2 4 13.3
11 3 3 1 24.0
12 3 4 2 31.0
13 4 1 4 26.3
14 4 2 3 27.1
15 4 3 2 39.1
16 4 4 1 44.2
k1 5.1 12.3 20.1
k2 12.0 13.7 20.6
k3 20.2 19.9 14.9
k4 34.2 25.6 15.9
D 29.1 13.3 5.70
Factors affecting the synthesis of the related 
substance E
The main controlling parameters during the 
production of clavulanic acid were the concentration of 
clavulanic acid, pH, and the temperature. We designed an 
orthogonal test to study their effect on the synthesis of the 
related substance E. The orthogonal design and the results 
are listed in Table I and Table II, respectively.
Range analysis showed that various factors affected 
the formation of the related substance E. The influence 
order was concentration of clavulanic acid> temperature 
>pH. Both concentration and temperature were significant 
in α=0.05 level. So we confirmed that they were the main 
factors affecting the synthesis of the related substance E, 
while the effect of pH was not obvious.
Results of the orthogonal experiment showed that 
the related substance E increased obviously when the 
concentration of clavulanic acid reached 150 g/L, which 
illustrated that the synthesis of the related substance E 
conformed to the law of mass action. As the content of 
the substrates increases, the probability of the collision 
among clavulanic acid molecules and their loop-opening 
degradation products is magnified and a new amide 
bond is generated. However, when the clavulanic acid 
concentration decreases, the synthesis of the related 
substance E decreases correspondingly, which may be the 
reason that the concentration of the related substance E 
increases obviously during the final fermentation.
Temperature was another factor affecting the 
synthesis of the related substance E. In general, the amide 
bond is relatively stable for the delocalization of the lone 
electron pair from the nitrogen atom itself, so it is prone 
to being hydrolysed under strong acid, alkali or heating 
conditions. Results showed that there were still trace amide 
bonds of clavulanic acid molecules breaking with the ring 
opened. The cleavage of the amide bond needs energy 
provided by the system. So the concentration of the related 
substance E decreased obviously at 5-10 °C, while the 
concentration increased significantly at 20 °C, during the 
orthogonal experiment, which proved that high temperature 
was favorable to provide energy for ring opening reaction. 
This may be the reason why the related substance E would 
be accumulated during the fermentation, although the 
concentration of clavulanic acid was low (0-4.87 g/L), but 
it was easier for the related substance E to form when the 
temperature is maintained at 28 °C.
Many studies showed that pH affected the stability 
of clavulanic acid, which was the vital factor to cause 
hydrolysis of clavulanic acid (Malcolm, 1984; Haginaka et 
al., 1985; Martin et al., 1989). Our results showed that pH 
had little impact on the formation of the related substance 
E in the pH range of 5.0-6.5, which was consistent with 
the fact that maintenance of pH 5.0-6.5 was beneficial to 
improve the quality of potassium clavulanate. In addition, 
the forming velocity of the related substance E was studied 
at nitrogen protection or exposure to air conditions. 
Although the higher productivity of secondary metabolites 
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was attainable through improving the oxygen supply during 
the culture process (Dick et al., 1994; Kaiser et al., 1994), 
Kim verified that active oxygen(s) could exert control on 
the expression of secondary metabolite biosynthesis (Kwon, 
Kim, 1999). In this study, oxygen had little effect on the 
generation of the related substance E (Table II).
Back extraction process conditions were optimized in 
according to the results of this study. The concentration of 
the related substance E decreased from an average of 0.18% 
to 0.03% with the decrease of clavulanic acid 150 g/L to 
100 g/L. The reaction temperature was adjusted from 15 °C 
to 5 °C, and pH was maintained at 5.5, which showed that 
the concentration of clavulanic acid and temperature are 
strongly correlated to the related substance E synthesis.
CONCLUSIONS
HPLC-MS/MS analysis proved the impurity with 
a retention time of 11.1 min is the related substance 
E, as noted in European Pharmacopoeia (2005). The 
related substance E is significantly formed during the 
concentration process after synthesis of clavulanic acid 
in the fermentation.
The forming mechanism of the related substance 
E involves the following steps: 1. a water attack to the 
molecule of clavulanic acid; 2. the opening of β-lactam 
ring amide bond, forming an amino group and a carboxylic 
group; 3. reaction of the amino group from a clavulanic 
acid molecule with the carboxylic group of another 
clavulanic acid molecule to form a new amide bond, 
generating the related substance E at the same time. 
Analysis of an orthogonal experiment showed that 
the concentration of clavulanic acid was the vital factor to 
promote the generation of the related substance E, while 
the temperature was another contributing factor. The pH 
had little impact on the generation of the related substance 
E in the range of 5.0-6.5.
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